The central puzzle the team set out to solve concerned the true function of the claudin-2 surge during infection. For years, the prevailing hypothesis held that the protein aids pathogen clearance by increasing the paracellular flux of sodium ions, thereby driving the watery diarrhea that flushes bacteria out of the intestinal lumen. Yet earlier work had shown that claudin-2 is dispensable for overall intestinal sodium homeostasis, which left the biological rationale for its induction unresolved. The researchers suspected a different explanation: rather than acting on the bulk movement of ions, claudin-2 might be reprogramming the epithelium itself, stimulating the rapid proliferation of cells within the intestinal crypts, the pocket-like invaginations that house stem cells and replenish the gut lining. Such proliferation had been observed during Citrobacter rodentium infection, but the molecular machinery driving it remained poorly understood.

To test this idea, the investigators turned to genetically engineered mice in which claudin-2 was either overexpressed specifically in the intestinal epithelium or deleted from it. When both groups were challenged with Citrobacter rodentium, the results were striking. Animals with elevated claudin-2 carried a markedly lower bacterial burden and suffered less colonic inflammation than their normal littermates. The knockout mice showed the opposite phenotype: higher colonization, exacerbated inflammatory damage, and a conspicuous failure of the crypts to mount the proliferative response that normally accompanies infection. These reciprocal outcomes established that claudin-2 is not a passive byproduct of inflammation but a decisive factor determining how successfully the intestinal barrier withstands an attaching-and-effacing bacterial pathogen.

Digging into the mechanism, the team identified a process they describe as crypt fetalization. During severe injury or infection, portions of the adult intestinal lining can revert to a gene-expression pattern resembling that of the fetal gut, a state associated with rapid cell division, enhanced wound healing, and improved tissue resilience. In the infected mice, claudin-2 promoted this fetal-like reprogramming of the crypts, whereas in the knockout animals the program was suppressed. The researchers used intestinal organoid cultures, miniature gut-like structures grown in vitro from epithelial stem cells, to confirm that the effect is intrinsic to the epithelium rather than a secondary consequence of immune signaling. Co-immunoprecipitation experiments then revealed the signaling complexes through which claudin-2 exerts its influence, anchoring the phenomenon in concrete molecular interactions rather than correlation alone.

The pathway the team mapped runs through three well-known signaling nodes: beta-1 integrin, focal adhesion kinase, and YAP. Claudin-2, according to their data, stabilizes the complex formed between beta-1 integrin, a matrix-binding receptor on the cell surface, and focal adhesion kinase, a cytoplasmic enzyme that transmits mechanical and adhesive signals into the cell. Stabilization of this complex activates FAK, which in turn triggers YAP, a transcriptional co-activator of the Hippo pathway that drives expression of growth and regeneration genes. With YAP active, crypt cells proliferate and adopt the fetal-like state that accelerates mucosal repair. In mice lacking claudin-2, this axis falls silent, the crypts fail to expand, and the damaged epithelium cannot regenerate quickly enough to limit bacterial colonization.

An additional experiment sharpened the causal chain by targeting the signal that initiates claudin-2 production in the first place. The researchers found that blocking activation of the epidermal growth factor receptor, EGFR, abolished the infection-induced upregulation of claudin-2 and reproduced the knockout phenotype, with increased bacterial burden and worsened colitis. This places EGFR upstream of claudin-2 in a coherent regulatory circuit: the pathogen or the tissue damage it causes activates EGFR, EGFR induces claudin-2, and claudin-2 engages the beta-1 integrin, FAK, and YAP cascade to reprogram the crypts. Interrupting the circuit at any point, the data suggest, leaves the gut vulnerable to the same infectious assault.

The clinical implications reach well beyond the mouse model. Enteropathogenic E. coli remains a major cause of diarrheal illness and childhood malnutrition worldwide, and attaching-and-effacing pathogens of this class depend on colonizing the epithelial surface. If claudin-2’s regenerative function operates similarly in humans, therapies designed to enhance its signaling could strengthen mucosal defenses during infection. The work also carries a cautionary message for inflammatory bowel disease research. Claudin-2 is consistently upregulated in ulcerative colitis and has been blamed for the barrier leakage that fuels chronic inflammation, prompting proposals to inhibit it. The new findings suggest that such a strategy could inadvertently strip the epithelium of a key repair mechanism, since the same protein that loosens tight junctions also appears to drive the regenerative response that heals the mucosa.

The study also adds to a growing appreciation that tight-junction proteins are signaling molecules in their own right rather than inert gaskets between cells. Claudin-7, for example, has recently been shown to maintain colonic stem cell homeostasis through Wnt and Notch signaling, indicating that the claudin family participates in developmental and regulatory programs throughout the gut. The demonstration that claudin-2 couples the epithelium’s adhesive machinery to YAP-driven proliferation provides a mechanistic template for how barrier proteins might coordinate physical sealing with biological renewal, two functions that must be balanced for the intestine to survive its constant exposure to microbes, toxins, and mechanical stress.

For now, the researchers emphasize that the work was conducted in mice and organoids, and that translating the beta-1 integrin, FAK, and YAP axis into human therapies will require further validation. Nevertheless, the conceptual shift is significant. A protein once studied almost exclusively as a channel for ions and water has emerged as a master regulator of mucosal defense, linking pathogen sensing through EGFR to structural regeneration through integrin mechanotransduction. As the authors conclude, claudin-2’s role in protecting against enteropathogenic infection and colitis extends far beyond its classical function in paracellular permeability, opening a new frontier in the search for treatments that help the gut heal itself.

Subject of Research: The role of claudin-2 in intestinal epithelial regeneration and defense against enteropathogenic bacterial infection

Article Title: Claudin-2 protects from enteropathogenic E. coli-infection and colitis by promoting crypt fetalization via β1-integrin/FAK/YAP signaling

Article References: Kumar, B., Ahmad, R., Talmon, G. A., Kapur, S., Oupicky, D., Dhawan, P., & Singh, A. B. (2026). Claudin-2 protects from enteropathogenic E. coli-infection and colitis by promoting crypt fetalization via β1-integrin/FAK/YAP signaling. Nature Communications. https://doi.org/10.1038/s41467-026-78238-w

Image Credits: AI Generated

DOI: 10.1038/s41467-026-78238-w

Keywords: claudin-2, enteropathogenic E. coli, Citrobacter rodentium, colitis, crypt fetalization, beta-1 integrin, FAK, YAP, EGFR, tight junctions, intestinal epithelium, mucosal defense

The intestinal epithelial barrier is the body’s frontline customs office, a single layer of cells that decides what passes from the gut lumen into the bloodstream and what stays out. Its defining feature is the tight junction, a belt of protein complexes that seals the gaps between neighboring epithelial cells. These junctions perform what biologists call a gate-and-fence function: they permit the selective passage of water, ions, and nutrients through the spaces between cells while blocking bacteria and their toxins. When tight junctions fail, the result is the condition popularly known as leaky gut, in which unwanted molecules slip through and provoke inflammatory responses. Disrupted barrier function is implicated in inflammatory bowel disease, metabolic disorders, and a growing list of chronic conditions.

The key players at these junctions are the tight junction proteins, including occludin and members of the claudin family. Occludin, the first of these proteins to be identified, stabilizes the structural framework of the junction. Claudin-2, one of several tissue-specific isoforms, is associated with permeability properties of the intestinal epithelium, and its behavior is subtle: depending on context, it can either loosen or remodel the barrier. Another important player is lipocalin-2, an antibacterial, iron-sequestering protein of innate immunity that participates in the barrier’s defensive repertoire and is often induced by inflammatory stimuli. The inflammatory cytokine tumor necrosis factor alpha, meanwhile, can undermine the barrier by triggering the internalization of occludin, raising permeability.

Probiotic lactobacilli have repeatedly been shown to bolster this system. Certain strains of Lactiplantibacillus plantarum increase the production and correct localization of tight junction proteins by upregulating the genes that encode them, thereby reducing permeability and guarding against inflammation. Researchers have also explored postbiotics, the cell-free supernatants left behind after bacterial growth, which contain the bioactive metabolites of probiotic cultures without the living cells themselves. What has remained murky is how the food matrix itself contributes when probiotics are delivered as part of a fermented food, rather than as a purified supplement. The new study set out to probe exactly that boundary.

The team, led by Jihen Missaoui with colleagues at the University of Bari Aldo Moro in Italy and the University of Monastir in Tunisia, worked with two lactobacilli previously isolated from traditional zgougou: Lactiplantibacillus paraplantarum A1 and Lactiplantibacillus plantarum A2. They prepared these bacteria in three forms: living cell biomass from liquid culture, cell-free supernatant from the same cultures, and zgougou juice fermented with both strains together as a starter consortium. For comparison, they also prepared zgougou juice that had fermented spontaneously, relying on whatever microbes happened to be present. Each preparation was applied to monolayers of Caco-2 cells, a human colon cancer cell line that, when grown for 21 days on Transwell inserts, differentiates into a faithful in vitro model of the intestinal epithelium.

To gauge barrier integrity, the researchers measured transepithelial electrical resistance, or TEER, a standard technique in which a small current is passed across the cell layer; higher resistance means tighter junctions and a less permeable barrier. As a positive control, they challenged cells with lipopolysaccharide, a component of the outer membrane of E. coli that reliably disrupts tight junctions. The LPS treatment produced the expected time-dependent response, with resistance dropping significantly within 30 minutes before partially recovering. Against this baseline, the effects of the bacterial preparations emerged clearly, though not uniformly.

Exposure to the biomass of L. paraplantarum A1 raised TEER values significantly at early time points, an effect that depended on both the dose and the dilution used. The cell-free supernatant of the same strain increased resistance after six hours, and the biomass and supernatant of L. plantarum A2 produced significant boosts at 30 minutes. The most striking result, however, came from the fermented food itself. When the monolayers were treated with zgougou juice fermented by the two lactobacilli together, diluted tenfold, TEER values climbed to between roughly 690 and 963 ohms per square centimeter at every time point measured, dramatically higher than the untreated control. Spontaneously fermented juice produced a smaller but still significant effect at one time point. The combination of the two strains, embedded in the pine seed matrix, outperformed anything the bacteria achieved alone.

The molecular story behind these measurements proved equally intriguing. Using reverse transcription quantitative PCR, the team measured the expression of genes encoding occludin, claudin-2, lipocalin-2, and TNF alpha after 24 hours of exposure. Both bacterial biomasses and the driven-fermented juice significantly increased TNF alpha gene expression, yet an ELISA assay of the culture medium detected no corresponding increase in the protein itself. The authors attribute this discrepancy to post-transcriptional regulatory mechanisms that can block cytokine synthesis even when the gene is actively transcribed, a reminder that messenger RNA levels do not always translate into protein output.

More encouraging were the tight junction results. Biomass and cell-free supernatant of both lactobacilli significantly upregulated the genes for occludin and lipocalin-2, with the strongest effects seen at the tenfold dilution. The fermented zgougou juice, whether driven by the starter cultures or fermented spontaneously, significantly increased expression of both claudin-2 and occludin, with the spontaneous juice producing the strongest upregulation. The apparent tension between rising claudin-2 expression and rising TEER, which might seem contradictory given claudin-2’s association with permeability, is resolved by context: the functional impact of claudin-2 depends on the overall composition of the junction complex, and its overexpression here likely signals junction remodeling and epithelial homeostasis rather than a leaky barrier.

The authors hypothesize that the observed effects arise from a synergy between the bioactive compounds of Aleppo pine seeds, which are rich in linoleic and alpha-linolenic acids, flavonoids, and phenolics with antioxidant and anti-inflammatory activity, and the metabolic activity of the fermenting lactobacilli. Vegetable matrices may also protect probiotic bacteria during their passage through the stomach and small intestine, releasing them in the colon where they can interact directly with the host. The study is the first to show that fermented zgougou juice can upregulate genes encoding tight junction proteins in an intestinal cell model, and it underscores how traditional fermented foods, from kefir to kimchi, may modulate gut permeability through the combined action of microbes, their metabolites, and plant phytochemicals. The researchers caution that the effects are strain-dependent and shaped by the host and its resident microbiota, and they call for untargeted metabolomics to identify the specific compounds responsible, followed by animal studies to confirm whether the barrier-reinforcing effect survives the journey from the dish to the organism.

Subject of Research: Effects of Tunisian fermented zgougou and probiotic lactobacilli on intestinal epithelial barrier integrity in Caco-2 cell models

Article Title: Impact of Tunisian Fermented Zgougou and Related Lactobacilli on Caco‐2 Cell Barrier Integrity: Upregulation of Key Tight Junction Proteins

Article References: Missaoui, J., Liso, M., Lataoui, M., Limongelli, R., Minervini, F., Achour, L., & De Angelis, M. (2026). Impact of Tunisian Fermented Zgougou and Related Lactobacilli on Caco‐2 Cell Barrier Integrity: Upregulation of Key Tight Junction Proteins. Food Science & Nutrition, 14(10), Article e72387. https://doi.org/10.1002/fsn3.72387

Image Credits: AI Generated

DOI: 10.1002/fsn3.72387

Keywords: zgougou, Aleppo pine seeds, fermented foods, lactobacilli, probiotics, gut barrier, tight junction proteins, occludin, claudin-2, Caco-2 cells, TEER, postbiotics